|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Securities available-for-sale, at fair value | ||||||||||||||||||||
| Securities held-to-maturity | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans held for investment, net of fees and costs | ||||||||||||||||||||
| Commercial and Industrial ("C&I") Loans | ||||||||||||||||||||
| Other Loans | ||||||||||||||||||||
| Total loans held for investment, net of fees and costs | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Commercial and Industrial ("C&I") Loans | ||||||||||||||||||||
| Other Loans | ||||||||||||||||||||
| Total allowance for credit losses | ||||||||||||||||||||
| Total loans held for investment, net | ||||||||||||||||||||
| Premises and fixed assets, net | ||||||||||||||||||||
| Premises held for sale | ||||||||||||||||||||
| Restricted stock | ||||||||||||||||||||
| Bank Owned Life Insurance ("BOLI") | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets | ||||||||||||||||||||
| Operating lease assets | ||||||||||||||||||||
| Derivative assets | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY: | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Interest-bearing deposits | ||||||||||||||||||||
| Non-interest-bearing deposits | ||||||||||||||||||||
| Deposits (excluding mortgage escrow deposits) | ||||||||||||||||||||
| Non-interest-bearing mortgage escrow deposits | ||||||||||||||||||||
| Interest-bearing mortgage escrow deposits | ||||||||||||||||||||
| Total mortgage escrow deposits | ||||||||||||||||||||
| Total deposits (including mortgage escrow deposits) | ||||||||||||||||||||
| Federal Home Loan Bank of New York ("FHLBNY") advances | ||||||||||||||||||||
| Other short-term borrowings | ||||||||||||||||||||
| Subordinated debt, net | ||||||||||||||||||||
| Derivative cash collateral | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Preferred stock, Series A ($0.01 par, $25.00 liquidation value, 10,000,000 shares authorized and 5,299,200 shares issued and outstanding at June 30, 2026 and December 31, 2025) | ||||||||||||||||||||
| Common stock ($0.01 par, 80,000,000 shares authorized, 46,154,333 and 46,151,302 shares issued at June 30, 2026 and December 31, 2025 respectively, and 44,158,358 shares and 43,862,327 shares outstanding at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of deferred taxes | ||||||||||||||||||||
| Unearned equity awards | ||||||||||||||||||||
| Treasury stock, at cost (1,995,975 shares and 2,288,975 shares at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
